Ehren and colleagues (2013) evaluated responses to CyA for 16 weeks (3 mg/kg/day for 12 weeks with reduced dosage for final four weeks) in 10 patients with Hunner ulcers
Cancer epidemiology context LeRoith & Roberts (2003) and Pollak (2008) summarize the body of evidence linking elevated circulating IGF-1 to risk of certain cancers
Support Your Gut Health At FormBlends, our physicians evaluate your gut health concerns and recommend the most appropriate peptide therapy, whether that's BPC-157, CJC-1295/Ipamorelin, or a combination
This medicine may be only part of a complete program of treatment that also includes making changes to your diet and taking other supplements
Some practitioners advocate weight-based dosing (e.g., 2.5-5 g/kg daily), while others use fixed doses (250-500 g daily) regardless of body size
But today the Committee looked at the evidence this industry built and said YES